Pafenolol
Pafenolol
 |
| Names |
| IUPAC name
1-[2-[4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl]ethyl]-3-propan-2-ylurea |
| Identifiers |
| |
80015-07-2 |
| ChemSpider |
64289 |
InChI=1S/C18H31N3O3/c1-13(2)20-11-16(22)12-24-17-7-5-15(6-8-17)9-10-19-18(23)21-14(3)4/h5-8,13-14,16,20,22H,9-12H2,1-4H3,(H2,19,21,23) InChI=1/C18H31N3O3/c1-13(2)20-11-16(22)12-24-17-7-5-15(6-8-17)9-10-19-18(23)21-14(3)4/h5-8,13-14,16,20,22H,9-12H2,1-4H3,(H2,19,21,23)
Key: PKWZWSXSCKVUJB-UHFFFAOYAJ
|
| Jmol-3D images |
Image |
| PubChem |
71144 |
CC(C)NCC(COC1=CC=C(C=C1)CCNC(=O)NC(C)C)O
|
| Properties |
| Molecular formula |
C18H31N3O3 |
| Molar mass |
337.46 g·mol−1 |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) |
|
| Infobox references |
|
|
Pafenolol is a beta adrenergic receptor antagonist.[1]
References
- ↑ Lennernäs, H; Regårdh, CG (1993). "Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat". Pharmaceutical Research 10 (5): 727–31. PMID 8100631.